vs

Side-by-side financial comparison of AUBURN NATIONAL BANCORPORATION, INC (AUBN) and IMMUCELL CORP (ICCC). Click either name above to swap in a different company.

AUBURN NATIONAL BANCORPORATION, INC is the larger business by last-quarter revenue ($8.5M vs $5.5M, roughly 1.5× IMMUCELL CORP). AUBURN NATIONAL BANCORPORATION, INC runs the higher net margin — 19.7% vs -2.5%, a 22.2% gap on every dollar of revenue. On growth, AUBURN NATIONAL BANCORPORATION, INC posted the faster year-over-year revenue change (8.4% vs -8.4%). AUBURN NATIONAL BANCORPORATION, INC produced more free cash flow last quarter ($10.9M vs $-1.8M). Over the past eight quarters, AUBURN NATIONAL BANCORPORATION, INC's revenue compounded faster (5.9% CAGR vs 3.9%).

Auburn Bank is an American community bank providing services in the East of Alabama as a state registered bank. The Bank offers financial products and services including checking, savings, and lending. The bank is a member of the Federal Home Loan Bank of Atlanta. Its operation is regulated by the Alabama Superintendent of Banks.

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

AUBN vs ICCC — Head-to-Head

Bigger by revenue
AUBN
AUBN
1.5× larger
AUBN
$8.5M
$5.5M
ICCC
Growing faster (revenue YoY)
AUBN
AUBN
+16.8% gap
AUBN
8.4%
-8.4%
ICCC
Higher net margin
AUBN
AUBN
22.2% more per $
AUBN
19.7%
-2.5%
ICCC
More free cash flow
AUBN
AUBN
$12.6M more FCF
AUBN
$10.9M
$-1.8M
ICCC
Faster 2-yr revenue CAGR
AUBN
AUBN
Annualised
AUBN
5.9%
3.9%
ICCC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AUBN
AUBN
ICCC
ICCC
Revenue
$8.5M
$5.5M
Net Profit
$1.7M
$-139.7K
Gross Margin
42.9%
Operating Margin
25.1%
0.4%
Net Margin
19.7%
-2.5%
Revenue YoY
8.4%
-8.4%
Net Profit YoY
6.7%
80.1%
EPS (diluted)
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUBN
AUBN
ICCC
ICCC
Q4 25
$8.5M
Q3 25
$8.4M
$5.5M
Q2 25
$8.1M
$6.4M
Q1 25
$7.8M
$8.1M
Q4 24
$7.8M
$7.8M
Q3 24
$7.6M
$6.0M
Q2 24
$7.6M
$5.5M
Q1 24
$7.5M
$7.3M
Net Profit
AUBN
AUBN
ICCC
ICCC
Q4 25
$1.7M
Q3 25
$2.2M
$-139.7K
Q2 25
$1.8M
$501.9K
Q1 25
$1.5M
$1.4M
Q4 24
$1.6M
Q3 24
$1.7M
$-701.7K
Q2 24
$1.7M
$-1.5M
Q1 24
$1.4M
$-437.9K
Gross Margin
AUBN
AUBN
ICCC
ICCC
Q4 25
Q3 25
42.9%
Q2 25
43.7%
Q1 25
41.6%
Q4 24
36.5%
Q3 24
26.3%
Q2 24
22.5%
Q1 24
31.6%
Operating Margin
AUBN
AUBN
ICCC
ICCC
Q4 25
25.1%
Q3 25
33.9%
0.4%
Q2 25
28.5%
8.8%
Q1 25
24.7%
13.9%
Q4 24
30.6%
8.0%
Q3 24
29.6%
-9.6%
Q2 24
29.0%
-25.3%
Q1 24
20.3%
-4.1%
Net Margin
AUBN
AUBN
ICCC
ICCC
Q4 25
19.7%
Q3 25
26.5%
-2.5%
Q2 25
22.5%
7.8%
Q1 25
19.6%
17.9%
Q4 24
20.0%
Q3 24
22.7%
-11.7%
Q2 24
22.8%
-28.0%
Q1 24
18.2%
-6.0%
EPS (diluted)
AUBN
AUBN
ICCC
ICCC
Q4 25
Q3 25
$0.64
$-0.02
Q2 25
$0.06
Q1 25
$0.16
Q4 24
$0.09
Q3 24
$0.50
$-0.09
Q2 24
$-0.20
Q1 24
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUBN
AUBN
ICCC
ICCC
Cash + ST InvestmentsLiquidity on hand
$3.9M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$92.1M
$29.8M
Total Assets
$1.0B
$45.7M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUBN
AUBN
ICCC
ICCC
Q4 25
Q3 25
$3.9M
Q2 25
Q1 25
Q4 24
$3.8M
Q3 24
Q2 24
$1.3M
Q1 24
$960.3K
Total Debt
AUBN
AUBN
ICCC
ICCC
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
AUBN
AUBN
ICCC
ICCC
Q4 25
$92.1M
Q3 25
$89.6M
$29.8M
Q2 25
$86.1M
$29.9M
Q1 25
$83.1M
$29.0M
Q4 24
$78.3M
$27.5M
Q3 24
$84.3M
$26.4M
Q2 24
$75.2M
$23.5M
Q1 24
$74.5M
$24.6M
Total Assets
AUBN
AUBN
ICCC
ICCC
Q4 25
$1.0B
Q3 25
$1.0B
$45.7M
Q2 25
$1.0B
$46.7M
Q1 25
$996.8M
$45.6M
Q4 24
$977.3M
$45.1M
Q3 24
$990.1M
$44.4M
Q2 24
$1.0B
$41.9M
Q1 24
$979.0M
$43.1M
Debt / Equity
AUBN
AUBN
ICCC
ICCC
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUBN
AUBN
ICCC
ICCC
Operating Cash FlowLast quarter
$12.3M
$-1.2M
Free Cash FlowOCF − Capex
$10.9M
$-1.8M
FCF MarginFCF / Revenue
128.3%
-32.3%
Capex IntensityCapex / Revenue
17.5%
10.8%
Cash ConversionOCF / Net Profit
7.42×
TTM Free Cash FlowTrailing 4 quarters
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUBN
AUBN
ICCC
ICCC
Q4 25
$12.3M
Q3 25
$4.1M
$-1.2M
Q2 25
$2.1M
$1.6M
Q1 25
$2.6M
$1.6M
Q4 24
$10.8M
$-3.1K
Q3 24
$1.9M
$-639.3K
Q2 24
$3.1M
$581.8K
Q1 24
$3.1M
$418.5K
Free Cash Flow
AUBN
AUBN
ICCC
ICCC
Q4 25
$10.9M
Q3 25
$-1.8M
Q2 25
$1.4M
Q1 25
$1.2M
Q4 24
$8.7M
$-199.3K
Q3 24
$-727.7K
Q2 24
$471.0K
Q1 24
$348.1K
FCF Margin
AUBN
AUBN
ICCC
ICCC
Q4 25
128.3%
Q3 25
-32.3%
Q2 25
22.4%
Q1 25
15.4%
Q4 24
111.6%
-2.6%
Q3 24
-12.1%
Q2 24
8.6%
Q1 24
4.8%
Capex Intensity
AUBN
AUBN
ICCC
ICCC
Q4 25
17.5%
Q3 25
10.8%
Q2 25
2.4%
Q1 25
4.1%
Q4 24
26.7%
2.5%
Q3 24
1.5%
Q2 24
2.0%
Q1 24
1.0%
Cash Conversion
AUBN
AUBN
ICCC
ICCC
Q4 25
7.42×
Q3 25
1.83×
Q2 25
1.17×
3.19×
Q1 25
1.72×
1.09×
Q4 24
6.93×
Q3 24
1.08×
Q2 24
1.76×
Q1 24
2.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons